P3 Health Partners Stock Analysis

PIII Stock  USD 0.17  0.01  6.25%   
P3 Health Partners is overvalued with Real Value of 0.16 and Target Price of 0.63. The main objective of P3 Health stock analysis is to determine its intrinsic value, which is an estimate of what P3 Health Partners is worth, separate from its market price. There are two main types of P3 Health's stock analysis: fundamental analysis and technical analysis.
The P3 Health stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and P3 Health's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in P3 Health Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

PIII Stock Analysis Notes

About 62.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.23. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. P3 Health Partners recorded a loss per share of 0.86. The entity had not issued any dividends in recent years. P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. P3 Health operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 523 people. To find out more about P3 Health Partners contact FACEP FACP at 702 910 3950 or learn more at https://p3hp.org.

P3 Health Quarterly Total Revenue

362.12 Million

P3 Health Partners Investment Alerts

P3 Health Partners had very high historical volatility over the last 90 days
P3 Health Partners has some characteristics of a very speculative penny stock
P3 Health Partners has high likelihood to experience some financial distress in the next 2 years
P3 Health Partners currently holds 121.94 M in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. P3 Health Partners has a current ratio of 0.74, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about P3 Health's use of debt, we should always consider it together with its cash and equity.
The entity reported the previous year's revenue of 1.27 B. Net Loss for the year was (57.77 M) with loss before overhead, payroll, taxes, and interest of (40.2 M).
P3 Health Partners currently holds about 63.15 M in cash with (76.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.52, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 62.0% of P3 Health outstanding shares are owned by corporate insiders
Latest headline from zacks.com: P3 Health Partners Could Find a Support Soon, Heres Why You Should Buy the Stock Now

P3 Health Partners Upcoming and Recent Events

Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to P3 Health previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
29th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

PIII Largest EPS Surprises

Earnings surprises can significantly impact P3 Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-08-07
2024-06-30-0.05-0.09-0.0480 
2023-08-07
2023-06-30-0.13-0.090.0430 
2024-05-08
2024-03-31-0.11-0.16-0.0545 
View All Earnings Estimates

PIII Stock Institutional Investors

Shares
Smh Capital Inc.2024-12-31
184.5 K
Cresset Asset Management, Llc2024-12-31
150 K
Warberg Asset Management Llc2024-12-31
145.3 K
Blair William & Co2024-12-31
125.8 K
Moneta Group Investment Advisors Inc2024-12-31
112.8 K
State Street Corp2024-12-31
101.4 K
Northern Trust Corp2024-12-31
100 K
Welch Capital Partners Llc2024-12-31
90 K
Prudential Investment Management Inc2024-09-30
88 K
Alyeska Investment Group, L.p.2024-12-31
11.9 M
Vanguard Group Inc2024-12-31
1.8 M
Note, although P3 Health's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

PIII Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 95.47 M.

PIII Profitablity

The company has Profit Margin (PM) of (0.07) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.31) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.31.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.34)(0.36)
Return On Capital Employed(0.27)(0.28)
Return On Assets(0.06)(0.06)
Return On Equity(0.47)(0.49)

Management Efficiency

P3 Health Partners has return on total asset (ROA) of (0.1825) % which means that it has lost $0.1825 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6545) %, meaning that it created substantial loss on money invested by shareholders. P3 Health's management efficiency ratios could be used to measure how well P3 Health manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.36. The current Return On Capital Employed is estimated to decrease to -0.28. As of now, P3 Health's Intangible Assets are decreasing as compared to previous years. The P3 Health's current Debt To Assets is estimated to increase to 0.24, while Total Assets are projected to decrease to under 938.8 M.
Last ReportedProjected for Next Year
Book Value Per Share 4.11  3.91 
Tangible Book Value Per Share(2.82)(2.97)
Enterprise Value Over EBITDA(2.33)(2.45)
Price Book Value Ratio 1.01  0.96 
Enterprise Value Multiple(2.33)(2.45)
Price Fair Value 1.01  0.96 
Enterprise Value278.5 M398.5 M
The operational strategies employed by P3 Health management play a crucial role in its market positioning. Assessing these strategies alongside financial data helps us evaluate the stock's investment potential.
Operating Margin
(0.31)
Profit Margin
(0.07)
Beta
0.928
Return On Assets
(0.18)
Return On Equity
(0.65)

Technical Drivers

As of the 24th of March, P3 Health owns the market risk adjusted performance of (0.25), and Information Ratio of (0.02). In connection with fundamental indicators, the technical analysis model allows you to check timely technical drivers of P3 Health Partners, as well as the relationship between them.

P3 Health Partners Price Movement Analysis

Execute Study
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. P3 Health middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for P3 Health Partners. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

P3 Health Partners Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific P3 Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on P3 Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases P3 Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Leisure Lawrence B. over a week ago
Acquisition by Leisure Lawrence B. of 216561 shares of P3 Health subject to Rule 16b-3
 
Park Jeffrey G over three months ago
Acquisition by Park Jeffrey G of 482640 shares of P3 Health at 0.5461 subject to Rule 16b-3
 
Bacchus Amir over three months ago
Acquisition by Bacchus Amir of 1000000 shares of P3 Health subject to Rule 16b-3
 
Erin Darakjian over three months ago
Acquisition by Erin Darakjian of 100000 shares of P3 Health subject to Rule 16b-3
 
Leif Pedersen over three months ago
Insider Trading
 
Chicago Pacific Founders Ugp Iii, Llc over six months ago
Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 80000 shares of P3 Health at 0.5591 subject to Rule 16b-3
 
Chicago Pacific Founders Ugp Iii, Llc over six months ago
Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 80000 shares of P3 Health at 0.4883 subject to Rule 16b-3
 
Chicago Pacific Founders Ugp Iii, Llc over six months ago
Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 90000 shares of P3 Health at 3.9969 subject to Rule 16b-3
 
Kazarian Gregory N. over six months ago
Acquisition by Kazarian Gregory N. of 482640 shares of P3 Health at 0.5461 subject to Rule 16b-3
 
Chicago Pacific Founders Ugp Iii, Llc over six months ago
Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 90000 shares of P3 Health at 1.4375 subject to Rule 16b-3
 
Leavitt Legacy Llc over a year ago
Acquisition by Leavitt Legacy Llc of 6708407 shares of P3 Health subject to Rule 16b-3
 
Wasson Gregory D over a year ago
Conversion by Wasson Gregory D of 6843525 shares of P3 Health

P3 Health Outstanding Bonds

P3 Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. P3 Health Partners uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most PIII bonds can be classified according to their maturity, which is the date when P3 Health Partners has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

P3 Health Predictive Daily Indicators

P3 Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of P3 Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

P3 Health Forecast Models

P3 Health's time-series forecasting models are one of many P3 Health's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary P3 Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About PIII Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how P3 Health prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling PIII shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as P3 Health. By using and applying PIII Stock analysis, traders can create a robust methodology for identifying PIII entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.17)(0.18)
Operating Profit Margin(0.15)(0.16)
Net Loss(0.04)(0.04)
Gross Profit Margin 0.03  0.03 

Current PIII Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. PIII analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. PIII analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
0.63Buy4Odds
P3 Health Partners current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most PIII analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand PIII stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of P3 Health Partners, talking to its executives and customers, or listening to PIII conference calls.
PIII Analyst Advice Details

PIII Stock Analysis Indicators

P3 Health Partners stock analysis indicators help investors evaluate how P3 Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading P3 Health shares will generate the highest return on investment. By understating and applying P3 Health stock analysis, traders can identify P3 Health position entry and exit signals to maximize returns.
Begin Period Cash Flow18.5 M
Total Stockholder Equity142.1 M
Capital Lease Obligations13.6 M
Property Plant And Equipment Net24 M
Cash And Short Term Investments36.3 M
Net Invested Capital250.4 M
Cash36.3 M
50 Day M A0.1955
Net Interest Income-14.9 M
Total Current Liabilities299.4 M
Investments-2 M
Interest Expense16 M
Stock Based CompensationM
Long Term Debt108.3 M
Common Stock Shares Outstanding294.6 M
Tax Provision2.8 M
Free Cash Flow-77.9 M
Operating Income-167.9 M
Other Current Assets4.6 M
Accounts Payable8.7 M
Net Debt85.6 M
Depreciation86.7 M
Other Operating Expenses1.4 B
Non Current Assets Total695 M
Liabilities And Stockholders Equity861 M
Non Currrent Assets Other4.2 M

Complementary Tools for PIII Stock analysis

When running P3 Health's price analysis, check to measure P3 Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy P3 Health is operating at the current time. Most of P3 Health's value examination focuses on studying past and present price action to predict the probability of P3 Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move P3 Health's price. Additionally, you may evaluate how the addition of P3 Health to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences